 Integra LifeSciences Holdings Corp NASDAQ: IART expects Q4 FY21 sales of 404 million - 406 million, representing an increase of approximately 4 YY on a reported basis and 8 on an organic basis. Interim Q4 sales beat the consensus of 403.9 million. 